• Wed, November 29, 2023
Michael Ulz Maintained (CABA) at Buy with Decreased Target to $25 on, Nov 29th, 2023
Michael Ulz of Morgan Stanley, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $28 to $25 on, Nov 29th, 2023.
Michael has made no other calls on CABA in the last 4 months.
There are 5 other peers that have a rating on CABA. Out of the 5 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Michael
- Joshua Schimmer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $50 on, Wednesday, November 15th, 2023
- Ben Burnett of "Stifel" Initiated at Strong Buy and Held Target at $31 on, Thursday, October 19th, 2023
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $39 on, Monday, September 18th, 2023
- Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $22 on, Tuesday, September 5th, 2023
- Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $34 on, Monday, August 14th, 2023
Like: 👍
